Quantinno Capital Management »

Celldex Therapeutics shares owned by Quantinno Capital Management

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Quantinno Capital Management from 13F filings

Historical chart of Quantinno Capital Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Quantinno Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Quantinno Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $641k 24k 27.16

More positions owned by Quantinno Capital Management

NVIDIA Corporation Put Option (NVDA)
Apple Put Option (AAPL)
Microsoft Corporation Put Option (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Reddit Cl A Put Option (RDDT)
JPMorgan Chase & Co. Put Option (JPM)
Eli Lilly & Co. Put Option (LLY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Quantinno Capital Management

Top funds holding Celldex Therapeutics

Kynam Capital Management
Wellington Management Company
BlackRock
FMR
Vanguard Group
Bellevue Group
State Street Corporation
Commodore Capital
Deep Track Capital
Braidwell
Point72 Asset Management
Eventide Asset Management
Geode Capital Management
Eversept Partners
Novo A/S

View all funds holding Celldex Therapeutics